-
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade BJU Int. (IF 3.7) Pub Date : 2024-12-19 Frederik F. Thomsen, Marcus Westerberg, Rasmus D. Petersson, Rasmine Bak, Julie Bak Lindholst, Hayder Al-Husseinawi, Emma Heeno, Nessn H. Azawi
To identify predictors of metastases, estimate the proportion of metastatic clear cell renal cell carcinoma (ccRCC) cases according to these predictors, and subsequently create a risk table showing the absolute difference in metastasis proportion for each 10 mm increase in tumour size.
-
Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life Eur. Urol. (IF 25.3) Pub Date : 2024-12-19 Marie-Pier St-Laurent, Bernard Bochner, James Catto, Benjamin J. Davies, Christian Daniel Fankhauser, Tullika Garg, Jill Hamilton-Reeves, Viraj Master, Bente T. Jensen, Susanne V. Lauridsen, Elizabeth Wulff-Burchfield, Sarah P. Psutka
Background and objectiveTreatment burden refers to the overall impact of medical treatments on a patient’s well-being and daily life. Our objective is to evaluate the impact of treatment burden on quality of life (QoL) in patients with genitourinary (GU) malignancies, highlighting the importance of patient-reported outcomes (PROs) in clinical trials to inform treatment decisions and improve patient
-
Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum Eur. Urol. (IF 25.3) Pub Date : 2024-12-18 Johan Stranne, Ann Henry, Daniela E. Oprea-Lager
No Abstract
-
Optimal Treatment Strategies for Hormone-sensitive Metastatic Prostate Cancer: Does Local Radiotherapy Play a Role in High-volume Disease? Eur. Urol. (IF 25.3) Pub Date : 2024-12-17 Steven Tisseverasinghe, Marwan Tolba, Fred Saad, Karim Fizazi, Boris Bahoric, Tamim Niazi
No Abstract
-
Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial. J. Urol. (IF 5.9) Pub Date : 2024-12-18 Ekene A Enemchukwu,Susan Kalota,Kaiser Robertson,Sijian Ge,Jingmei Lu,Hanh Badger,Salim Mujais,Kenneth M Peters
PURPOSE To assess efficacy and safety of URO-902, an investigational gene therapy expressing the α subunit of the large-conductance Ca2+-activated K+ channel, in a phase 2a placebo-controlled trial in women with overactive bladder (OAB). MATERIALS AND METHODS Women, 40‒79 years, with OAB and urge urinary incontinence (UUI) who were refractory to OAB medications were randomized to single-dose URO-902
-
The Discrepancy Between Patient-reported Outcomes, Adverse Events, and Radiographic Progression-free Survival in MAGNITUDE and Other Recent Trials Eur. Urol. (IF 25.3) Pub Date : 2024-12-17 Celestia S. Higano
No Abstract
-
Biparametric Versus Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Choice or a Fine Balance? Eur. Urol. (IF 25.3) Pub Date : 2024-12-16 Adriano B. Dias, Caroline M. Moore, Raphaële Renard-Penna, Francesco Giganti
No Abstract
-
Stimulated Raman Histology and Artificial Intelligence Provide Near Real-Time Interpretation of Radical Prostatectomy Surgical Margins. J. Urol. (IF 5.9) Pub Date : 2024-12-17 Miles P Mannas,Fang-Ming Deng,Adrian Ion-Margineanu,Christian Freudiger,Lea Lough,William Huang,James Wysock,Richard Huang,Steve Pastore,Derek Jones,Deepthi Hoskoppal,Jonathan Melamed,Daniel A Orringer,Samir S Taneja
INTRODUCTION Balancing surgical margins and functional outcomes is crucial during radical prostatectomy for prostate cancer. Stimulated Raman Histology (SRH) is a novel, real-time imaging technique that provides histologic images of fresh, unprocessed, and unstained tissue within minutes, which can be interpreted by either humans or artificial intelligence. METHODS Twenty-two participants underwent
-
Long-Term Decision Regret and Associated Factors Following Urinary Reconstruction in Underserved Patients with Spinal Cord Injury. J. Urol. (IF 5.9) Pub Date : 2024-12-17 Aidin Abedi,Luis Morales Ojeda,Stefania Montero,Nhi Ha,Priya Kohli,Petr Gaburak,Armita Abedi,David Chapman,Evgeniy Kreydin,David A Ginsberg
PURPOSE Patients with refractory neurogenic bladder dysfunction may require urinary reconstruction due to severe incontinence, difficulty with catheterization, and to prevent upper urinary tract compromise. We evaluated long-term decisional regret and associated factors following urinary reconstruction in spinal cord injury patients. MATERIALS AND METHODS We interviewed patients with spinal cord injuries
-
Sharing surgical images on social media: a snapshot of practices and some reflections for improvement BJU Int. (IF 3.7) Pub Date : 2024-12-16 Patrick Juliebø‐Jones, Vineet Gauhar, Ali Talyshinskii, Christian Arvei Moen, Ingunn Roth, Lazaros Tzelves, Christian Beisland, Bhaskar K Somani
Click on the article title to read more.
-
Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice Eur. Urol. (IF 25.3) Pub Date : 2024-12-13 Rana R. McKay, Joshua Lang, Himisha Beltran
No Abstract
-
-
-
-
Balancing Efficacy and Cardiotoxicity in Prostate Cancer Therapy: A Call for Precision in Treatment Strategies Eur. Urol. (IF 25.3) Pub Date : 2024-12-12 Omar El-Taji, Noel W. Clarke
High-risk, potentially lethal prostate cancer (PCa) requires systemic androgen deprivation therapy (ADT), with doublet therapy offering superior anticancer effects in comparison to monotherapy, and triplet therapy being more effective than doublet. However, nothing comes without a cost. In the review of such combination therapies by Aziz et al [1] in this issue of European Urology, the authors endeavour
-
-
Impact of patient positioning during surgery on neuropathies after robot‐assisted laparoscopic radical prostatectomy: a randomised controlled trial BJU Int. (IF 3.7) Pub Date : 2024-12-13 Nico Christian Grossmann, Fabian Joel Aschwanden, Julian Cornelius, Christian Malkmus, Leutrim Zahiti, Pascal Viktorin, Lea Fierley, Einar Wilder‐Smith, Philipp Baumeister, Agostino Mattei, Christian Daniel Fankhauser
ObjectiveTo investigate whether ankle braces or shoulder support used for fixation during robot‐assisted radical prostatectomy (RARP), where patients are commonly positioned in the head‐down Trendelenburg position, differ in their potential to cause peripheral nerve injury.Patients and MethodsA prospective, double‐blind, randomised controlled trial was conducted on patients undergoing RARP for prostate
-
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour BJU Int. (IF 3.7) Pub Date : 2024-12-11 Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Armon Amini, Fady Baky, Nicolas Branger, Walter Cazzaniga, Timothy N. Clinton, Siamak Daneshmand, Hooman Djaladat, Scott Eggener, Alireza Ghoreifi, Robert J. Hamilton, Matthew Ho, Wade J. Sexton, Sebastiano Nazzani, David Nicol, Nicola Nicolai, Kathleen Olson, Pia Paffenholz, James Porter, Zhiyu Qian, Nicholas R. Rocco, Anirudh Yerrapragada, Sean P
To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients with CS 2b and to evaluate surgical methods, recurrence, and adjuvant chemotherapy indications.
-
Multiparametric Magnetic Resonance Imaging with Targeted-only Biopsy—A New Standard for Guidelines on Prostate Cancer Detection? Eur. Urol. (IF 25.3) Pub Date : 2024-12-12 John W. Davis
No Abstract
-
Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy with Intracorporeal Ileal Conduit. J. Urol. (IF 5.9) Pub Date : 2024-12-12 Jacob E Tallman,Emily A Vertosick,Syed M Alam,Fady J Baky,S Machele Donat,Eugene J Pietzak,Eugene K Cha,Timothy F Donahue,Bernard H Bochner,Andrew J Vickers,Alvin C Goh
PURPOSE Ureteral stents are commonly placed intraoperatively during radical cystectomy, though their efficacy in reducing complications is unproven. We compared clinical outcomes among patients undergoing robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC) with or without ureteral stents to determine if omission of ureteral stents affects postoperative complications. MATERIALS
-
The Upper TRACT Endometry Score: development and internal validation of an objective measure of variables that impact endoscopic procedures for upper tract urothelial carcinoma. J. Urol. (IF 5.9) Pub Date : 2024-12-12 Suzanne Lange,Alec Reinhardt,Daniel Igel,Craig Labbate,Mehrad Adibi,Suprateek Kundu,Surena Matin
PURPOSE Endoscopic management (EM) is an increasingly accepted option for upper tract urothelial carcinoma (UTUC). Feasibility can be dependent on a variety of variables. The objective of this study was to identify anatomic and phenotypic tumor characteristics that impact EM, using structured expert forecasting, develop and obtain consensus on an assessment score, and perform initial validation of
-
Long-term Urinary and Sexual Outcomes in Pediatric Genitourinary Rhabdomyosarcoma Survivors: A Qualitative Study. J. Urol. (IF 5.9) Pub Date : 2024-12-12 Rachel A Saunders,Andrea K Balthazar,Christopher D Jaeger,Monah Javidan-Nejad,Candace Y Chung,Judith A Vessey,Richard S Lee,Hsin-Hsiao Scott Wang
PURPOSE Genitourinary rhabdomyosarcoma (GU-RMS) often requires multimodal therapy treatment including radiation, chemotherapy, and radical surgery for disease control. The long-term effects of the disease and associated treatments are unclear. We sought to investigate the long-term genitourinary quality of life for adult survivors of pediatric GU-RMS. MATERIALS AND METHODS In total, 14 subjects (43%
-
Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer BJU Int. (IF 3.7) Pub Date : 2024-12-12 Mattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, Fabian Falkenbach, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali, Markus Graefen, Gennaro Musi, Felix K. H. Chun, Fred Saad, Shahrokh F. Shariat, Marco Moschini, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz
ObjectivesIt is not known whether cancer‐specific mortality (CSM) differences distinguish radical cystectomy (RC) from trimodal therapy (TMT) in octogenarians harbouring organ‐confined (T2N0M0) urothelial cancer of the urinary bladder (UCUB).MethodsWithin the Surveillance, Epidemiology, and End Results database (2004–2021), CSM and other‐cause mortality (OCM) rates were computed in octogenarian patients
-
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes BJU Int. (IF 3.7) Pub Date : 2024-12-12 Dhruv Puri, Margaret F. Meagher, Zhenjie Wu, Antonio Franco, Linhui Wang, Vitaly Margulis, Raj Bhanvadia, Firas Abdollah, Marco Finati, Alessandro Antonelli, Francesco Ditonno, Nirmish Singla, Stephan Broenimann, Giuseppe Simone, Gabriele Tuderti, Soroush Rais‐Bahrami, Sol C. Moon, Matteo Ferro, Marco Tozzi, Francesco Porpiglia, Daniele Amparore, Andreas Correa, Emma Helstrom, Mark L. Gonzalgo, Dinno
ObjectiveTo investigate the prevalence, predictors and impact of surgically induced chronic kidney disease (CKD‐S) on survival outcomes in patients with upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU).MethodsUtilising the ROBUUST 2.0 registry, a multicentre retrospective analysis was conducted in patients with UTUC undergoing RNU between 2006 and 2022 who did not
-
The role of social media in education: how to maximise learning BJU Int. (IF 3.7) Pub Date : 2024-12-12 Thomas Hughes, Bhaskar K Somani
Click on the article title to read more.
-
Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update Eur. Urol. (IF 25.3) Pub Date : 2024-12-11 Elizabeth J. Schafer, Mathieu Laversanne, Hyuna Sung, Isabelle Soerjomataram, Alberto Briganti, William Dahut, Freddie Bray, Ahmedin Jemal
Background and objectiveOur aim was to examine worldwide patterns and trends for prostate cancer (PC) incidence and mortality using high-quality, up-to-date, population-based data. MethodsWe analyzed age-standardized PC incidence and mortality rates by country and region from the 2022 GLOBOCAN estimates and temporal trends in incidence (50 countries/territories) and mortality (59 countries/territories)
-
-
-
-
-
-
-
Predicting surgical outcome for renal tumours Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-11 Isobel Leake
A new 3D method of calculating contact surface area (CSA) for renal tumours is reported in Urologic Oncology. This method can reliably predict perioperative outcomes following robot-assisted partial nephrectomy (RAPN). Several scores can be used to assess renal tumour complexity and complications, including R.E.N.A.L. and PADUA, but these scores were developed prior to the concept of 3D reconstruction
-
Diagnosis of ccRCC Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-11 Isobel Leake
Diagnosis of clear cell renal cell carcinoma (ccRCC) is challenging, particularly as [18F]FDG PET–CT is not routinely recommended. Novel single-domain antibody (sdAb) tracers could be useful in cancer imaging owing to their small size and high target recognition. In the first part of a study published in the Journal of Nuclear Medicine, Zhou et al. analysed CD70 expression in RCC and normal kidney
-
Virtual reality for nephrolithotomy Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-11 Isobel Leake
Percutaneous nephrolithotomy (PCNL) is the main surgical option for the management of large or complex renal stones. A study in the Journal of Urology investigated whether immersive virtual reality (iVR) could improve surgical planning and clinical outcomes in patients undergoing PCNL. Patients undergoing PCNL (n = 175) were randomly allocated to a CT-only or CT plus iVR group. The iVR models incorporated
-
Personalized 3D models for prostate cancer surgery Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-11 Maria Chiara Masone
Nerve-sparing surgery is the standard approach used in radical prostatectomy to enhance functional outcomes, but secondary resection might be needed in case of uncertainty regarding the complete removal of the tumour. However, direct visual guidance for resecting positive surgical margins (PSMs) during secondary resection is lacking. In a study published in BJU International, a 3D-printed prostate
-
Neoadjuvant therapy in MIBC Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-11 Isobel Leake
Efficacious neoadjuvant therapy is an unmet need in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC). Several early-phase clinical trials have investigated the use of immune checkpoint inhibitors (ICIs) in this context, with some promising results. A study in Nature Medicine set out to test whether the efficacy of ICIs could be improved in combination with other therapies. Cretostimogene
-
New findings regarding predictors of Poor Corporal Integrity in Penile Implant Recipients: A Multicenter International Invesigation BJU Int. (IF 3.7) Pub Date : 2024-12-11 Chrystal Chang, David W. Barham, Zafardjan Dalimov, Daniel Swerdloff, Hossein Sadeghi‐Nejad, Robert Andrianne, Maxime Sempels, Tung‐Chin Hsieh, Georgios Hatzichristodoulou, Muhammed Hammad, Jake Miller, Daniar Osmonov, Aaron Lentz, Paul Perito, Alfredo Suarez‐Sarmiento, James Hotaling, Kelli Gross, James M Jones, Koenraad van Renterghem, Sung Hun Park, Jonathan N. Warner, Matthew Ziegelmann, Vaibhav
ObjectivesTo evaluate the pre‐ and intraoperative variables that impact the integrity of the corporal bodies over time after inflatable penile prosthesis (IPP) placement, as predictors of intraoperative corporal perforation and delayed cylinder complications have not been well characterized.Patients and MethodsWe retrospectively reviewed a 16‐centre multi‐institutional database of IPP surgeries performed
-
Impact of Discordance Between MRI and US Volume Measurements on Prostate Fusion Biopsy Outcomes. J. Urol. (IF 5.9) Pub Date : 2024-12-10 Tabea Borde,Nicole A Varble,Lindsey A Hazen,Laetitia Saccenti,Charisse Garcia,Meredith Digennaro,Sandeep Gurram,Peter A Pinto,Baris Turkbey,Bradford J Wood
PURPOSE To determine whether the difference between MRI-based and ultrasound (US)-based volume measurements are associated with MRI/US-targeted fusion-guided biopsy outcomes. MATERIALS AND METHODS This retrospective, single-center study involved 4177 consecutive patients biopsied between 2010 and 2023 using both MRI/US-targeted fusion and systematic biopsy. Biopsies were indicated because of elevated
-
The Journal of Urology® Home Study Course 2025 Volume 213/214. J. Urol. (IF 5.9) Pub Date : 2024-12-10
-
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function BJU Int. (IF 3.7) Pub Date : 2024-12-10 Eiftu S. Haile, Zaeem Lone, David Shin, Amy S. Nowacki, Nicolas Soputro, Kyle Harris, Rebecca A. Campbell, Andrew Wood, Samuel C. Haywood, Mohamed Eltemamy, Georges‐Pascal Haber, Christopher J. Weight, Hadley M. Wood, Jonathan J. Taliercio, Amanda Nizam, Shilpa Gupta, Erick M. Remer, Nima Almassi
ObjectivesTo assess whether the effect of sarcopenia on neoadjuvant chemotherapy (NAC) toxicity is modified by borderline renal function (estimated glomerular filtration rate [eGFR] 40–65 mL/min) and whether sarcopenia and borderline renal function are independently associated with NAC toxicity risk.Patients and MethodsAll patients with muscle‐invasive bladder cancer (MIBC) who underwent radical cystectomy
-
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer BJU Int. (IF 3.7) Pub Date : 2024-12-10 Kennedy E. Okhawere, Shirin Razdan, Alp Tuna Beksac, Indu Saini, Laura Zuluaga, Kirolos Meilika, Burak Ucpinar, Ren‐Dih Sheu, Reza Mehrazin, John Sfakianos, Ashutosh Tewari, Richard G. Stock, Ketan Badani
ObjectiveTo investigate the safety and cancer control of a novel bioabsorbable, low‐dose rate brachytherapy device, CivaSheet® (CivaTech Oncology Inc., Durham, NC, USA), in combination with radical prostatectomy (RP) with or without adjuvant external beam radiation therapy (EBRT) for the management of prostate cancer (PCa).Patients and MethodsThis is an initial, single‐centre experience, two‐dose level
-
A Prostate Imaging‐Reporting and Data System version 2.1‐based predictive model for clinically significant prostate cancer diagnosis BJU Int. (IF 3.7) Pub Date : 2024-12-10 David G. Gelikman, William S. Azar, Enis C. Yilmaz, Yue Lin, Luke A. Shumaker, Andrew M. Fang, Stephanie A. Harmon, Erich P. Huang, Sahil H. Parikh, Jason A. Hyman, Kyle Schuppe, Jeffrey W. Nix, Samuel J. Galgano, Maria J. Merino, Peter L. Choyke, Sandeep Gurram, Bradford J. Wood, Soroush Rais‐Bahrami, Peter A. Pinto, Baris Turkbey
ObjectivesTo develop and validate a Prostate Imaging‐Reporting and Data System (PI‐RADS) version 2.1 (v2.1)‐based predictive model for diagnosis of clinically significant prostate cancer (csPCa), integrating clinical and multiparametric magnetic resonance imaging (mpMRI) data, and compare its performance with existing models.Patients and MethodsWe retrospectively analysed data from patients who underwent
-
Diagnostic and prognostic genomic aberrations in upper tract urothelial carcinoma can be identified in focal barbotage samples BJU Int. (IF 3.7) Pub Date : 2024-12-10 Tomas Andri Axelsson, Filip Sydén, Jesper Eisfeldt, Ylva Eriksson, Gustav Göthner Lundberg, Georg Jaremko, Ollanta Cuba Gyllensten, Emma Tham, Marianne Brehmer
ObjectivesTo investigate whether genetic analysis of focal barbotage samples obtained at ureterorenoscopy (URS) is possible, and to identify genetic aberrations that might add prognostic information.MethodsThis prospective study included barbotage samples from 42 patients with upper urinary tract urothelial carcinoma (UTUC) confirmed at URS. At URS, focal barbotage specimens were collected for cytology
-
-
January's reviewers of the month BJU Int. (IF 3.7) Pub Date : 2024-12-10
Click on the article title to read more.
-
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’ BJU Int. (IF 3.7) Pub Date : 2024-12-10 Rachana Mehta, Ashok Kumar Balaraman, Ganesh Bushi, Sanjit Sah
Click on the article title to read more.
-
Serial ctDNA to understand PARPi resistance Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-09 Annette Fenner
Poly(ADP-ribose) polymerase inhibition (PARPi) is an effective therapy for castration-resistant prostate cancer (CRPC) with defects in homologous recombination repair (HRR) genes. However, resistance to PARPi can arise, for example via mutations that restore BRCA function. Reversion mutations in HRR genes can result in PARPi resistance, but these cannot arise in patients with homozygous mutations,
-
The mechanism of action of neuromodulation in the treatment of overactive bladder Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-09 Jan Krhut, Hanne Kobberø, Reine Kanaan, Mikkel Fode, Mads Poulsen, Peter Zvara
-
Artificial Intelligence as a Discriminator of Competence in Urological Training: Are we there? J. Urol. (IF 5.9) Pub Date : 2024-12-09 Naji J Touma,Ruchit Patel,Thomas Skinner,Michael Leveridge
INTRODUCTION Assessments in medical education play a central role in evaluating trainees' progress and eventual competence. Generative artificial intelligence (AI) is finding an increasing role in clinical care and medical education. The objective of this study is to evaluate the ability of the large language model ChatGPT to generate exam questions that are discriminating in the evaluation of graduating
-
Development of Prediction Models for Severe Pain and Urinary Symptoms after Ureteroscopy with Ureteral Stent Placement: Results from the STENTS Study and Initial Validation of Pain Interference. J. Urol. (IF 5.9) Pub Date : 2024-12-09 Gregory E Tasian,Jonathan D Harper,Hussein R Al-Khalidi,Hongqiu Yang,Naim M Maalouf,Michele Curatolo,H Henry Lai,Alana Desai,Jodi A Antonelli,Jing Huang,Justin B Ziemba,Hunter Wessells,Ziya Kirkali,Charles D Scales,Peter P Reese
PURPOSE We developed prediction models for severe pain and urinary symptoms after ureteroscopy with ureteral stent placement. MATERIALS AND METHODS The development cohort included 424 adults and adolescents enrolled in the multicenter STENTS prospective cohort study who underwent ureteroscopy with stent placement for urinary stones. The validation cohort was an independent prospective cohort of 115
-
Development and Validation of the Length, Segment, and Etiology (LSE) Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data from the Trauma and Urologic Reconstruction Network of Surgeons. J. Urol. (IF 5.9) Pub Date : 2024-12-09 Bradley A Erickson,Mei N Tuong,Alithea N Zorn,Charles H Schlaepfer,Nejd F Alsikafi,Benjamin N Breyer,Joshua A Broghammer,Jill C Buckley,Sean P Elliott,Jeremy B Myers,Andrew C Peterson,Keith F Rourke,Thomas G Smith,Alex J Vanni,Bryan B Voelzke,Lee C Zhao
PURPOSE To create and validate an anterior urethral stricture disease (aUSD) staging system based on the previously validated Length (L), Urethral Segment (S), and Etiology (E, LSE) classification system. MATERIALS/METHODS The Trauma and Urologic Reconstruction Network of Surgeons (TURNS) prospective database was used to create and validate the staging system. A novel Urethroplasty Triad Score (UTS)
-
Diagnostic Test Characteristics of Ultrasound-Based Hydronephrosis for Chronic Kidney Disease in Children and Adolescents With Myelomeningocele: Results From the UMPIRE and NSBPR Cohort Studies. J. Urol. (IF 5.9) Pub Date : 2024-12-09 David I Chu,Tiebin Liu,Tonya Williams,Jacqueline Mix,Jennifer Ahn,J Christopher Austin,Michelle Baum,Douglass Clayton,Susan Jarosz,David Joseph,Elizabeth Roth,Jonathan Routh,Duong Tu,Evalynn Vasquez,M Chad Wallis,John Wiener,Earl Cheng,Elizabeth Yerkes,Stacy Tanaka
PURPOSE Renal ultrasounds are performed in patients with myelomeningocele to screen for markers of kidney health, including hydronephrosis. We evaluated the diagnostic accuracy of hydronephrosis to screen for low kidney function defined by estimated glomerular filtration rate (eGFR). MATERIALS AND METHODS We performed a retrospective cross-sectional study using data from 2 cohorts of children and youth
-
PEACEing together prostate cancer therapy Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-06 Louise Lloyd
Results of the PEACE-1 open-label, randomized, controlled, phase III trial have been published in The Lancet. In this study, the efficacy and safety of adding prostate radiotherapy to the treatment regimen in de novo metastatic castration-sensitive prostate cancer was investigated. In total, 1,172 men were randomly assigned to receive standard of care or standard of care plus abiraterone, plus radiotherapy
-
PFOA affects androgen metabolism Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-06 Louise Lloyd
A novel, endocrine-disrupting property of the perfluoroalkyl substance perfluorooctanoic acid (PFOA) affecting androgen metabolism has been discovered. This discovery has implications for our understanding of the effect of PFOA on the actions of androgens. In spectrofluorimetric inhibitor screens and inhibition studies, PFOA was identified to potently, competitively and specifically inhibit aldo-keto
-
JAK–STAT signalling and prostate basal cell fate Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-06 Louise Lloyd
A rare intermediate population of basal cells expressing luminal markers has been identified. Markers of this cell population include Nkx3.1, Pbsn, C1rb, Fgl1 and Mmp7. In these cells, termed Basal-B cells, activated JAK–STAT signalling was identified and its inhibition reduced expression of the markers characterizing these cells. Inflammation increased Basal-B cell-to-luminal cell transdifferentiation
-
Better PrEParation for HIV prevention in minority groups Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-06 Louise Lloyd
In a phase III, double-blind, randomized, active-controlled trial, receipt of twice-yearly subcutaneous lenacapavir every 26 weeks as pre-exposure prophylaxis (PrEP) significantly reduced HIV incidence in cisgender men, transgender women, transgender men and gender non-binary persons. Of 3,265 included participants, 2 in the lenacapavir group were diagnosed with HIV (0.10 per 100 person-years) compared
-
Robot-assisted radical prostatectomy haemostasis techniques and outcomes Nat. Rev. Urol. (IF 12.1) Pub Date : 2024-12-05 Gal Wald, Joshua Winograd, Mark Farha, Vanessa Dudley, Jim C. Hu
The robot-assisted approach to radical prostatectomy has enabled same-day discharge. A substantial concern associated with this practice could be haemorrhage, but sound and thorough robot-assisted radical prostatectomy haemostasis surgical techniques that were introduced to prevent bleeding mitigate this phenomenon.
-
The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study BJU Int. (IF 3.7) Pub Date : 2024-12-04 Jikke Bosveld, Tri Q. Nguyen, Joost L. Boormans, J. Alfred Witjes, Antoine G. van der Heijden, Niven Mehra, Lambertus A. Kiemeney, Katja K.H. Aben, , Richard P. Meijer, Anke Richters
To evaluate whether surgical margin status, alongside existing postoperative risk indicators, improves the identification of bladder cancer patients who may benefit from adjuvant therapy following radical cystectomy (RC).
-
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers Eur. Urol. (IF 25.3) Pub Date : 2024-12-05 Pedro C. Barata, Kevin K. Zarrabi, Axel Bex, Petros Grivas, Ken Hermann, Michael S. Hofman, Roger Li, Antonio Lopez-Beltran, Anwar R. Padani, Thomas Powles, Mary-Ellen Taplin, Yohann Loriot
Background and objectiveAdvances in molecular diagnostics have ushered in a new era for patients with prostate, renal, and urothelial cancers, with novel radiographic and molecular modalities for the assessment of disease burden and minimal residual disease (MRD). Conventional imaging has a limited threshold for disease detection and is often unable to discern clinically occult disease with varying